Merck & Co Inc. Blog | Talkmarkets

Latest Posts

Merck Strikes $773M Deal For Privately Held Tilos Therapeutics

Article By: Benzinga

Monday, June 10, 2019 2:00 PM EDT

Keeping in line with the biotech M&A frenzy seen for much of the year, Merck & Co., Inc. announced a deal to buy Tilos Therapeutics.

In this article: MRK

Read

Week In Review: How Trump's Policies Moved Stocks - May 12, 2019

Article By: The Fly

Sunday, May 12, 2019 6:43 AM EDT

Catch up on the top industries and stocks that were impacted, by the comments, actions and policies of President Donald Trump and his administration with this weekly recap.

In this article: AZN, BMY, GM, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, WKHS

Read

Dogs Of The Dow Lag Broader Market

Article By: David Templeton

Saturday, April 27, 2019 5:38 PM EDT

The magnitude of the market strength this year and the Dow Dogs' income focus are contributing to the underperformance of the Dow Dogs

In this article: JPM, MRK, VZ, CVX, IBM, KO, PG, CSCO

Read

E Rexahn's Deal With China For RX-3117 Candidate Moves It Back On The Right Track

Article By: Terry Chrisomalis

Tuesday, April 16, 2019 4:43 PM EDT

Rexahn Pharma generates a deal in Greater China for its clinical cancer product. Here's what you need to know...

In this article: RNN, MRK

Read

Week In Review: China's Cytovant Signs $1 Billion Deal For Four Medigene I-O Candidates

Article By: ChinaBio® Today

Saturday, April 6, 2019 5:16 PM EDT

Cytovant Sciences, a China cell therapy startup, announced a $1 billion partnership with Germany's Medigene to develop four of Medigene's T cell immunotherapy products in China.

In this article: MRK, NVS

Read

All Posts